This is a letter in response to the article by Chang and colleagues.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
August 20, 2015
This is a letter in response to the article by Chang and colleagues. The authors warn to interpret the findings of the original article, that SABR is better tolerated and might lead to improved survival compared to surgery for good risk patients with clinical stage I NSCLC, with caution. They highlight two pitfalls of the original study.
August 20, 2015
This is a letter in response to the article by Chang and colleagues. The authors begin by stating that the data from this study should be graded according to an internationally accepted system, GRADE.
August 19, 2015
This is a letter in response to the article by Chang and colleagues. The authors state that this type of analysis was necessary as it is difficult to conduct a clinical trial that involves new technology.
August 19, 2015
This is the authors' reply to the letters submitted to The Lancet Oncology. They begin by stating that the strength of their analysis was that patients were randomised, thereby avoiding selection bias. With regards to low accrual, one major factor was failure of thoracic surgeons to participate. In addition, stage I NSCLC is relatively uncommon.
August 17, 2015
This video demonstrates a left pneumonectomy by single-port approach for a primary squamous cell carcinoma.
August 11, 2015
This single institution retrospective study evaluated the relationship of adenocarcinoma subtype to long-term survival after resection of stage I lung cancer. Patients with solid-predominant tumors experienced recurrences earlier, more often in distant sites, and more often in multiple locations. This subtype was also independently associated with
August 4, 2015
This video shows a technique for the gradual transition from a conventional 3/4-port, to a 2-port, and finally to a single-port approach for thoracoscopic anatomic lung resections.
July 30, 2015
The ESMO Guidelines Committee provides an update to its guidelines for evaluation and management of malignant pleural mesothelioma. They recommend against screening. A biopsy demonstrating tissue invasion is required for a definitive diagnosis. Definitions for different extents of surgical radicality are provided. No specific recommendations for
July 27, 2015
The authors present a patient with a suspected cT1aN0 NSCLC right nodule, who was treated with a VATS anatomical segmentectomy.